Breaking AI & Tech News Analyzed

Study Shows Fetal Exposure to Vegetable Flavours Influences Post‑Birth PreferencesThe research team gave pregnant volunteers powdered kale or carrot capsules during the third trimester and later measured their children’s facial reactions to the same smells. Reactions were recorded via ultrasound before birth, repeated at three weeks, and again when the children were about three years old.Methodology: Kale and Carrot Powder Capsules Administered to Expectant MothersParticipants were asked to swallow a capsule each day containing either kale or carrot powder. The study avoided large volumes of juice, which many volunteers found unpalatable, opting for a low‑cost capsule format.Capsules administered in late pregnancy (around 32 weeks gestation).Initial chemosensory response captured with ultrasound imaging.Follow‑up assessments at 3 weeks and 3 years post‑birth.Sample Size and Observed Reactions Reveal Early Flavor MemoryAlthough the cohort was modest, the findings were consistent:12 children were observed at age three.Infants exposed to carrot powder smiled when presented with a carrot scent and grimaced at kale, and vice‑versa for the kale group.The same preference pattern was evident in the ultrasound scans before birth.These results suggest that flavour exposure in utero can create a durable chemosensory memory.Potential Public‑Health Benefits of Early Dietary ConditioningIf replicated on a larger scale, the approach could offer a low‑cost strategy for improving population nutrition:Reducing childhood resistance to vegetables may lower long‑term risks of obesity and diet‑related diseases.Capsules are inexpensive and could be integrated into routine prenatal supplements.The concept is adaptable to different cultural diets, as noted by the researchers’ interest in fish‑rich Japanese diets.Next Steps: Larger Trials and Cross‑Cultural ApplicationsThe authors acknowledge the need for a bigger, funded study to confirm the effect across diverse populations. Future research aims to:Expand the sample size to hundreds of mother‑child pairs.Test additional flavours and odourants, including artificial sweeteners.Explore policy pathways for incorporating flavour‑exposure capsules into prenatal care guidelines.Published in Developmental Psychobiology, the paper titled “Do Human Fetuses Form Long‑Lasting Chemosensory Memories?” opens a new avenue for early nutritional interventions.

The Lead: Australia's Spin Strategy for World Cup RedemptionAustralia's women's cricket team has unveiled a squad for the T20 World Cup with a clear focus on spin bowling, featuring captain Sophie Molineux's return alongside world-class spinners Ashleigh Gardner, Alana King, and Georgia Wareham. The team aims to bounce back from recent semi-final exits in major tournaments with this strategic selection.The Spin Selection DilemmaThe return of a fully fit Sophie Molineux from a lower back issue has created a selection squeeze for Australia, who already boast a formidable spin trio. Molineux, who has succeeded retired captain Alyssa Healy, will be a lock in the side despite the abundance of spin options. Chief selector Shawn Flegler confirmed that all four spinners could potentially play in the same side, with conditions determining the final combination.The Spinners' CredentialsAustralia's spin options are exceptionally strong. Alana King took a record 7-18 against South Africa in last year's 50-over World Cup and was player of the series after collecting 23 wickets in last year's Ashes triumph. King returned to the side after being left out of the India tour and took five wickets at an average of 11 in the West Indies, conceding just 5.5 runs an over while bowling in the powerplay.The Pace Attack ChangesThe pace bowling options have seen changes, with 20-year-old left-arm quick Lucy Hamilton included in the 15-player squad, while Darcie Brown was the surprise omission. Hamilton, who debuted in all three formats for Australia in March, brings a rare left-arm pace option in women's cricket. Coach Shelley Nitschke praised Hamilton's ability to get good bounce and bowl a heavy ball, noting it's a real point of difference for the attack.Squad Composition and ExperienceThe squad blends experience with new energy. Ellyse Perry will feature in her 10th T20 World Cup, having been part of every edition since the inaugural tournament in 2009. Allrounder Nicola Carey returns after a three-year absence, while Grace Harris is back after being left out of the recent West Indies tour. Annabel Sutherland also returns after missing the West Indies tour.Tournament Preparation and OutlookAustralia will play five warm-up games in England and Wales before their T20 World Cup campaign begins against South Africa on June 13. They'll play three warm-up matches at Arundel Castle against South Africa, starting on May 31, before a pair of practice games against England in Cardiff. The team is motivated by recent semi-final exits in major tournaments and aims to perform better in those crucial moments.

The Abrupt End of Australia's Sprint CampaignKaden Groves, Australia's premier sprinting hope at the 2026 Giro d'Italia, has been forced to abandon the race due to injuries sustained in a mass crash during the opening stage in Bulgaria. The 27-year-old, who was aiming to surpass Caleb Ewan's 11 Grand Tour stage wins and move second on the Australian all-time winners' list, joins compatriot Jay Vine in exiting the race prematurely due to crash-related injuries.The Opening Stage Crash That Changed the RaceGroves was among several riders injured in a mass crash occurring just 600 meters from the finish line as the race opened in Bulgaria on Friday. Despite appearing bloodied and limping immediately after the incident, his team Alpecin Premier-Tech initially reported that he seemed "OK." However, it later became clear that the 10-time Grand Tour stage winner was suffering from shoulder and neck bruising that proved more serious than initially assessed."I didn't ride yesterday. I hope after a complete day off the sensations have improved. I'll take it day by day and see how things are on the climb. I don't need to risk anything," Groves said before his withdrawal, indicating the severity of his condition despite his initial description of the injuries as "just a few superficial scrapes all over my body."Australian Cycling Suffers Double BlowThe withdrawal of Groves compounds a difficult start to the Giro for Australian cycling, following Jay Vine's earlier exit due to concussion and a broken elbow suffered in a crash on stage two. The two high-profile departures significantly reduce Australia's representation in the race's competitive aspects.In the absence of their big name duo Mathieu van der Poel and Jasper Philipsen, the Belgian team had anointed Groves, who was wearing No 1 in the race, as their main sprinter. With his exit, Francesco Busato will now lead Alpecin's sprinting efforts, though 25-year-old Australian Jensen Plowright may also receive opportunities after finishing 18th on stage three.Race Dynamics Shift as Sprinters ExitThe absence of key sprinters has altered the competitive landscape of the Giro. Ecuador's Jhonatan Narvaez capitalized on the changing dynamics to win stage four, providing a welcome boost for Vine's UAE Team Emirates XRG. Orluis Aular (Movistar) finished second, while Giulio Ciccone took third place and claimed the race leader's pink jersey.Two Australian general classification contenders remain in the race, with Red Bull-BORA hansgrohe's co-leader Jai Hindley and Jayco AlUla's Ben O'Connor both sitting handily 10 seconds behind new race leader Ciccone, alongside pre-race favorite Jonas Vingegaard (Visma Lease-A Bike).The Challenge Ahead: Mountain Stages AwaitWith sprinters exiting the race, attention now shifts to the climbers as the Giro prepares for its most demanding stages. Wednesday's fifth stage features nearly 4000m of climbing on the 203km route from Praia a Mare to Potenza, a profile that could significantly shake up the general classification standings.For Groves, the withdrawal represents a setback in his quest to add to his career tally of 10 Grand Tour stage victories. The Australian had just returned after a break of more than two months with knee trouble following a crash in the Omloop Het Nieuwsblad race at the start of March, making this latest injury particularly frustrating for the 27-year-old sprinter.

ACCESS: Medicare’s First AI‑Enabled Outcome‑Based Payment Model Pair Team was announced on April 30 as one of 150 organizations accepted into ACCESS (Advancing Chronic Care with Effective, Scalable Solutions), a CMS initiative that launches on July 5. The program shifts reimbursement from traditional time‑based fees to payments tied to measurable health outcomes such as lower blood pressure or reduced pain, covering conditions like diabetes, hypertension, chronic kidney disease, obesity, depression, and anxiety. Revenue Scale and Funding Behind Pair Team Staff: roughly 850 clinical professionals, the largest community‑health workforce in California. Revenue: exceeds nine figures (>$100 million) annually. Capital raised: about $30 million from investors including Kleiner Perkins, Kraft Ventures, and Next Ventures. Patient reach: partnerships give access to ~500,000 potential patients, with a goal of 1 million within three years. Industry context: digital‑health funding hit its highest Q1 total since the pandemic, with AI firms capturing the bulk of new capital. How Outcome‑Based Payments Could Redefine Chronic Care Delivery The ACCESS model creates the first federal mechanism to pay for AI agents that monitor patients between visits, coordinate social services, and ensure medication adherence. Flora, Pair Team’s voice‑AI assistant, now handles 24/7 intake, referrals, and check‑ins, delivering hour‑long conversations that act as both clinical touchpoints and companionship for high‑needs patients. Peer‑reviewed research in the Journal of General Internal Medicine shows Pair Team’s community‑integrated approach cuts avoidable emergency and inpatient utilization, with one‑in‑four hospital visits and one‑in‑two ER visits averted for its members. Risks remain: the program funnels highly sensitive data into a federal system with a history of breaches, and past CMS innovation pilots have drawn criticism for increasing federal spending without delivering projected savings. What’s Next for AI‑First Health Providers Under ACCESS Batlivala argues that lower per‑patient reimbursement rates are intentional, forcing providers to adopt lean, AI‑driven operations. As the program scales, success will hinge on: Automating patient interactions to keep costs below payment thresholds. Demonstrating measurable outcome improvements across the covered chronic conditions. Managing data‑privacy concerns to maintain trust among vulnerable populations. Attracting additional capital as investors watch the first AI‑centric Medicare payment model unfold. If Pair Team and its peers can prove the model’s efficacy, ACCESS could become a template for nationwide AI‑enabled, outcome‑based reimbursement, reshaping how Medicare incentivizes technology in health care.

Jason Collins' Death Marks End of a Pioneering NBA JourneyJason Collins, the league’s first openly gay player, passed away on May 12, 2026 after an eight‑month battle with an aggressive brain tumor. The family announced his death, noting his impact as both a player and an ambassador for inclusion.Key Career Milestones and the Final BattleCollins spent 13 years in the NBA, suiting up for six franchises, most notably the Boston Celtics and the New Jersey Nets. In 2013, he publicly came out, a move that reshaped the league’s cultural landscape. In his final weeks, he was honored with the inaugural Bill Walton Global Champion Award at the Green Sports Alliance Summit, accepted on his behalf by his twin brother, former NBA player Jarron Collins.Numbers That Highlight a Life of ImpactAge at death: 47NBA tenure: 13 yearsTeams played for: 6Diagnosis: Stage 4 glioblastoma (extremely low survival rate)Duration of illness: 8 monthsRipple Effects on LGBTQ Representation and Health AwarenessCollins’ openness paved the way for greater LGBTQ visibility in professional sports, inspiring athletes to live authentically. His battle with glioblastoma also spotlights the need for heightened medical support and research funding for brain‑tumor patients within athletic communities.What This Means for Future Advocacy in SportsStakeholders are likely to amplify initiatives that combine diversity, equity, and inclusion (DEI) with health‑care advocacy. Expect more leagues to partner with medical charities, and for former players to use their platforms to champion both LGBTQ rights and neurological disease awareness.

A Sudden Tragedy Shocks the GrizzliesBrandon Clarke, the 29‑year‑old forward for the Memphis Grizzlies, was found dead at a home in California’s San Fernando Valley, the team announced on Tuesday. No cause of death has been released.Details of Clarke’s Passing and Career HighlightsClarke was born in Vancouver, Canada, and entered the NBA as the 21st overall pick in the 2019 draft, originally selected by the Oklahoma City Thunder before his rights were traded to Memphis on draft night. He spent his entire career with the Grizzlies, earning a spot on the NBA All‑Rookie First Team in 2020 after averaging 12.1 points and 5.9 rebounds in his debut season.Injuries—including knee, calf, Achilles issues—limited his availability; he appeared in only two games during the 2025‑26 season and has missed 174 of a possible 246 games over the past three seasons.Career Statistics and Recent Playing TimeAverage career: 10.2 points and 5.5 rebounds per game over seven seasons2025‑26 season: 2 games playedContract: multiyear extension signed in October 2022Ramifications for Memphis Grizzlies and the NBA CommunityThe Grizzlies issued a statement describing Clarke as “an outstanding teammate and an even better person,” while NBA Commissioner Adam Silver called him “a beloved teammate and leader.” The loss affects not only the roster but also the broader Memphis community, where Clarke was active in outreach.What Lies Ahead for the Grizzlies Without ClarkeWith Clarke’s contract still in effect, the team will need to address the roster spot and salary cap implications while seeking to fill the leadership void. The Grizzlies may look to develop younger forwards or explore trade options to maintain competitiveness in the Western Conference.

OpenAI CEO Sam Altman testified on Tuesday in an Oakland federal courtroom, confronting allegations from Elon Musk that the company breached its founding agreement by converting to a for‑profit structure.Altman’s Testimony Highlights the For‑Profit Conversion DisputeDuring his appearance, Altman recounted his career and directly addressed Musk’s claims that he “swindled” Musk into co‑founding OpenAI and that the nonprofit was improperly turned into a profit‑driven venture. He emphasized that discussions about a for‑profit arm in 2017 never materialised due to ownership disagreements and that Musk’s demand for total control made him uncomfortable.Financial Stakes: $134 bn Redistribution Claim and $1 tn Valuation Target$134 bn – amount Musk seeks to redistribute to OpenAI’s nonprofit side.$1 tn – valuation OpenAI aims for in its upcoming public offering.Three‑week trial duration, with closing arguments scheduled for Thursday.Implications for OpenAI’s IPO Plans and AI Industry GovernanceThe outcome will shape OpenAI’s ability to proceed with its planned IPO and could set precedents for how hybrid nonprofit‑profit AI entities are regulated. A ruling against OpenAI might force a restructuring that could delay or diminish the $1 tn market debut, while a victory would reinforce the current governance model that separates nonprofit oversight from for‑profit operations.What the Closing Arguments Could Mean for OpenAI’s FutureWith the jury set to deliberate after Thursday’s closing statements, analysts anticipate three possible scenarios: (1) a verdict that upholds OpenAI’s structure, clearing the path for the IPO; (2) a partial ruling requiring financial adjustments but allowing the company to remain operational; or (3) a full reversal that could trigger a major re‑organization or sale. Stakeholders are watching closely as the decision will influence investor confidence across the broader AI sector.

The Sudden Passing of Brandon Clarke Memphis Grizzlies forward Brandon Clarke has died at the age of 29, his sports agency has confirmed. “We are beyond devastated by the passing of Brandon Clarke,” Priority Sports said. “He was so loved by all of us here, and everyone whose life he touched. He was the gentlest soul who was the first to be there for all of his friends and family. Our hearts are so broken as we think about his mom, Whitney, his entire family and all of his friends. From high school to San Jose State to Gonzaga to the Grizzlies, Brandon impacted everyone who was part of his life.” Clarke's Basketball Career and Community Impact Clarke had a standout college career with San Jose State and Gonzaga before he was picked by the Oklahoma City Thunder with the 21st overall selection of the 2019 draft. He was named to the NBA All-Rookie team in his first season in Memphis. He signed a four-year extension with the Grizzlies in 2022 but missed most of the past season after undergoing knee surgery. Clarke was born in Vancouver before his family moved to the United States when he was a child. He was active in the Memphis community and celebrated his 29th birthday by donating books and resources to a local elementary school. Clarke's Legacy and Off-Court Contributions “Every time I talk to kids, I try to get that in their minds that school is important, teachers are important and grades matter,” Clarke told the Memphis Commercial Appeal. “I couldn’t have made it here without locking in on reading, writing and all of that stuff.”

The LeadRobert Smith, a distinguished pharmacologist and professor at St Mary's medical school in London (now part of Imperial College), has died aged 92. His groundbreaking work on how genetic variations affect drug responses helped shape the field of personalized medicine.The Discovery of Debrisoquine PolymorphismBob became well known for his role in the discovery of "debrisoquine polymorphism." In 1975, as one of five volunteer researchers who took debrisoquine, a blood pressure medication, he was the only one to suffer adverse effects (hypotension) and collapse. This led to the discovery of a genetic polymorphism where certain individuals cannot break down specific drugs efficiently. While Bob described this as an "accident waiting to happen," it positioned him at the forefront of pharmacogenetics.Awards and RecognitionSmith's contributions to pharmacology were formally recognized when he became the first recipient of the Paton prize in 1998 for his work in understanding how genes affect drug response. His academic achievements included becoming professor of pharmacology in 1978 and serving as deputy dean of the medical school from 1980-88.Impact on Medicine and SportsSmith's research fundamentally changed how medical professionals understand drug responses, paving the way for personalized medicine approaches. Beyond human medicine, he applied these principles to horse racing, chairing the UK Horserace Scientific Advisory Committee (1979-99) and its pan-European equivalent (1992-2005). He also served as a director of the Horseracing Forensic Laboratory in Newmarket during the 1990s, helping shape anti-doping protocols.Enduring LegacySmith never fully retired, continuing his research as emeritus professor until publishing his last paper in 2020. His legacy extends beyond scientific contributions to include the principles, warmth, kindness and generosity he embodied throughout his career. His work continues to influence pharmacology and personalized medicine, ensuring his impact will be felt for generations to come.